Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 0
No TA breakdown available.
R&D Momentum
80/100
Pipeline Velocity
55/100
Trial Completion Rate
74/100
Pipeline Concentration
100/100
Pipeline Freshness
74/100
Activity
Last 14 days
A Novel Continuous Glucose Monitoring Enhanced DPP Intervention to Prevent Type 2 Diabetes in Adults With Prediabetes
Clinical, Genetic, and Cellular Consequences of Mutations in the NA,K-ATPase ATP1A3
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
Feasibility of Aerobic Exercise for Recovery From Work-related Concussion
Community Pharmacies as Social Determinant of Health Navigators
Robotic Rehabilitation for Stroke Survivors
The Institute for Myelin and Glia Exploration's Clinical Database of Patients With Krabbe Disease, A World-Wide Registry
Surveying Patient's Interest in Robotic Rehabilitation Device
Cannabis Use and Outcomes in Black and White Patients With Cancer
Repurposing Lithium as a Disease-modifying Therapy in Parkinson's Disease: A Randomized Controlled Trial
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)